Natera Inc (NTRA)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$328.18+0.16%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · NTRA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 2,707.1 | 2,306.1 | 1,696.9 | 1,082.6 | 820.2 | 625.5 | 391.0 | 302.3 | 257.7 | 210.9 | 217.1 | 190.4 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 210.9 | 217.1 | 190.4 |
| Cost of Revenues | — | — | — | — | — | — | — | — | 158.1 | — | — | — |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | 1,255.0 | 1,177.3 | 841.3 | 618.3 | 588.6 | 511.0 | 303.6 | 206.2 | 154.9 | 155.3 | 136.1 | 109.6 |
| R&D Expenses | 787.4 | 624.1 | 404.1 | 320.7 | 316.4 | 264.2 | 100.0 | 51.4 | 51.4 | 50.1 | 41.9 | 27.7 |
| Operating Income | (289.7) | (309.9) | (222.3) | (446.2) | (541.0) | (468.2) | (216.3) | (116.3) | (114.6) | (135.3) | (101.1) | (59.8) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | 4.1 | 10.7 | 12.6 | 9.3 | 8.3 | 15.1 | 10.7 | 10.5 | 4.2 | 0.5 | 3.5 |
| Asset Writedown | — | — | — | — | — | 0.0 | — | 1.7 | 1.5 | 0.6 | 2.1 | 1.6 |
| EBT, Incl. Unusual Items | (252.7) | (268.1) | (189.7) | (434.5) | (546.8) | (471.1) | (229.6) | (122.8) | (127.8) | (137.2) | (100.2) | — |
| Income Tax Expense | (60.4) | (59.9) | 0.7 | 0.3 | 1.0 | 0.6 | 0.1 | 2.0 | 0.3 | 0.5 | 0.1 | 0.0 |
| Net Income | ||||||||||||
| Net Income | (192.3) | (208.2) | (190.4) | (434.8) | (547.8) | (471.7) | (229.7) | (124.8) | (128.2) | (137.6) | (100.3) | (70.3) |
| Per Share | ||||||||||||
| Basic EPS | (1.34) | (1.52) | (1.53) | (3.78) | (5.57) | (5.21) | (2.84) | (1.79) | (2.22) | (2.58) | — | — |
| Diluted EPS | (1.34) | (1.52) | (1.53) | (3.78) | (5.57) | (5.21) | (2.84) | (1.79) | (2.22) | (2.59) | — | — |
| Revenue per Share | 18.89 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 143.3 | 136.7 | 124.7 | 115.0 | 98.4 | 90.6 | 81.0 | 69.6 | 57.8 | 53.3 | — | — |
| Diluted Weighted Avg Shares | 143.3 | 136.7 | 124.7 | 115.0 | 98.4 | 90.6 | 81.0 | 69.6 | 57.8 | 53.6 | — | — |
| Supplemental | ||||||||||||
| EBITDA | — | (268.1) | (191.3) | (422.1) | (524.3) | (456.9) | (207.7) | (108.6) | (107.1) | (128.2) | (94.9) | (54.3) |
| EBIT | (289.7) | (309.9) | (222.3) | (446.2) | (541.0) | (468.2) | (216.3) | (116.3) | (114.6) | (135.3) | (101.1) | (59.8) |
| Effective Tax Rate | 23.9% | — | — | -0.1% | -0.2% | -0.1% | -0.0% | -1.6% | -0.3% | -0.3% | -0.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.